⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SABSW News
Form 8-K
sec.gov
SABS
SABSW
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
globenewswire.com
SABS
SABSW
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
globenewswire.com
SABS
SABSW
Form 8-K
sec.gov
SABS
SABSW
Form 8-K
sec.gov
SABS
SABSW
Form 8-K
sec.gov
SABSW
SABS
Form 8-K
sec.gov
SABS
SABSW
SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
globenewswire.com
SABS
SABSW
SAB BIO to Present Additional Data Supporting the Unique Profile of SAB-142 at the 2026 Immunology of Diabetes Society Congress
globenewswire.com
SABS
SABSW
Form 8-K
sec.gov
SABS
SABSW